Detalhe da pesquisa
1.
2,5-Disubstituted pyridines as potent GPR119 agonists.
Bioorg Med Chem Lett
; 20(8): 2577-81, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20227877
2.
Facile reductive amination of aldehydes with electron-deficient anilines by acyloxyborohydrides in TFA: application to a diazaindoline scale-up.
J Org Chem
; 74(9): 3587-90, 2009 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19351107
3.
Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1).
J Med Chem
; 48(18): 5837-52, 2005 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-16134950
4.
Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 2).
J Med Chem
; 48(18): 5853-68, 2005 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-16134951
5.
Discovery of 6,7-dihydro-5H-pyrrolo[2,3-a]pyrimidines as orally available G protein-coupled receptor 119 agonists.
J Med Chem
; 55(24): 10972-94, 2012 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-23214471
6.
Synthesis of the Azabicyclic Core of the Azinomycins: Introduction of Differentiated trans-Diol by Crotylstannane Addition to Serinal.
J Org Chem
; 63(17): 5738-5739, 1998 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-11672166
7.
Novel benzimidazole-based MCH R1 antagonists.
Bioorg Med Chem Lett
; 16(19): 4994-5000, 2006 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16904318
8.
Discovery process and characterization of novel carbohydrazide derivatives as potent and selective GHSR1a antagonists.
ChemMedChem
; 5(9): 1450-5, 2010 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20593439